Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
QbD Manoeuvred Niclosamide Laden Polylactic-co-Glycolic Acid Nanoparticles-Impregnated Gelatin Nanofibers for the Management of Oral Carcinoma
Saurabh Shah, Paras Famta, Rahul Kumar, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 4
Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 13
An ensemble machine learning-based performance evaluation identifies top In-Silico pathogenicity prediction methods that best classify driver mutations in cancer
Subrata Das, Vatsal Patel, Shouvik Chakravarty, et al.
BioData Mining (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
Jarosz-Biej Magdalena, Czapla Justyna, C Renshaw Joanna, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access | Times Cited: 1
An Open Access Database of Licensed Cancer Drugs
Pan Pantziarka, Rica Capistrano, Arno De Potter, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
Huzaifa Yasir Khan, Mohammad Fawad Ansari, Sartaj Tabassum, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104055-104055
Closed Access | Times Cited: 7
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 6
Recent advanced lipid-based nanomedicines for overcoming cancer resistance
Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Integrating GWAS and Transcriptome Data through PrediXcan and Multimodal Deep Learning to Reveal Genetic Basis and Novel Drug Repositioning Opportunities for Alzheimer's Disease
Xuecong Tian, Ying Su, Sizhe Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Advancing Cancer Drug Delivery with Nanoparticles: Challenges and Prospects in Mathematical Modeling for In Vivo and In Vitro Systems
Tozivepi Aaron Munyayi, Anine Crous
Cancers (2025) Vol. 17, Iss. 2, pp. 198-198
Open Access
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of Oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase
Xiaobin Wang, Shulin Li, Zichen Li, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Targeting breast cancer stem cells in ER-positive breast cancer by repurposing the benzoporphyrin derivative verteporfin as a YAP/TAZ small molecule inhibitor
Priyanka Dey Talukdar, Himansu Roy, Urmi Chatterji
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity
Ritika Kurian, Hongbing Wang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 988-988
Open Access
Insights into the apoptosis induction in colon cancer cells by Ag-Cu bimetallic nanocomposite: 2D tissue culture model and insilico study
Jalal Abbas, Buthenia A. Hasoon, Majid S. Jabir
Inorganic Chemistry Communications (2025), pp. 114019-114019
Closed Access
Advantages, Challenges, and Impact of Drug Repurposing for Cancer Treatment
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1+ TAMs and CD8+ T cells
Fangyuan Dong, Shan Zhang, Kaiyuan Song, et al.
(2025)
Open Access
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1+ TAMs and CD8+ T cells
Fangyuan Dong, Shan Zhang, Kaiyuan Song, et al.
(2025)
Open Access
Half‐Sandwich Organometallic Ir(III) and Ru(II) Compounds and their Interactions with Biomolecules
Sandra Kozieł, Daria Wojtala, Magdalena Szmitka, et al.
ChemPlusChem (2025)
Open Access
Biomimetic Atorvastatin Self-Assembled Nanomedicine Inhibit the Cyclooxygenase-2/prostaglandin E2 Pathway Enhanced Photothermal and Antitumor Immunity
Min Zhou, Ruyue Han, Wenjie Xu, et al.
Biomaterials Research (2025)
Open Access
Editorial: Drug repurposing for cancer treatment: current and future directions
Marios Lampros, Nikolaos Vlachos, Georgios D. Lianos, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Role of circular RNAs in cancer therapy resistance
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study
CC Foo, Jiaxi Li, Zheng Huang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top